New Shorter Treatments for Tuberculosis
Author Information
Author(s): Salomon Joshua A, Lloyd-Smith James O, Getz Wayne M, Resch Stephen, Sánchez María S, Porco Travis C, Borgdorff Martien W
Primary Institution: Harvard School of Public Health
Hypothesis
What are the potential benefits of introducing shorter treatment regimens for tuberculosis?
Conclusion
Shorter treatment regimens for tuberculosis could significantly reduce the incidence and mortality rates of the disease.
Supporting Evidence
- A 2-month regimen could prevent around 20% of new TB cases and 25% of TB deaths in South-East Asia by 2030.
- Shorter regimens could lead to a 2- or 3-fold increase in the rates of decline in TB incidence and mortality.
- Delaying the introduction of new drugs could erase nearly three-fourths of the expected benefits.
Takeaway
If we can give people shorter treatments for tuberculosis, more people will get better faster, and fewer will get sick or die from it.
Methodology
A mathematical model was developed to evaluate the impact of shorter treatment durations on tuberculosis dynamics.
Potential Biases
The model does not account for the potential development of resistance to new drugs.
Limitations
The model makes several assumptions that may not hold true in all real-world scenarios.
Participant Demographics
The study focuses on the South-East Asia region, which includes high-burden countries for tuberculosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website